RVL Pharmaceuticals Plc
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RVLPQ and buy or sell other stocks, ETFs, and their options commission-free!About RVLPQ
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, Lorzone, and M-72.
CEOBrian A. Markison, CPA
CEOBrian A. Markison, CPA
Employees125
Employees125
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1986
Founded1986
Employees125
Employees125
RVLPQ Key Statistics
Market cap0.00
Market cap0.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.57K
Average volume3.57K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume100.00
Volume100.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, RVL Pharmaceuticals Plc(RVLPQ) shares are valued at $0.00. The company's market cap stands at 0.
On 2026-03-12, RVL Pharmaceuticals Plc(RVLPQ) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for RVL Pharmaceuticals Plc(RVLPQ) stock has reached 100, versus its average volume of 3.57K.
Over the past 52 weeks, RVL Pharmaceuticals Plc(RVLPQ) stock has traded between a high of $0.00 and a low of $0.00.
Over the past 52 weeks, RVL Pharmaceuticals Plc(RVLPQ) stock has traded between a high of $0.00 and a low of $0.00.
People also own
Based on the portfolios of people who own RVLPQ. This list is generated using Robinhood data, and it’s not a recommendation.